Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Flexion Therapeutics, Inc. (FLXN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
9.27-0.04 (-0.43%)
At close: 4:00PM EDT
9.27 0.00 (0.00%)
After hours: 04:42PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close9.31
Open9.31
Bid9.22 x 1800
Ask9.27 x 1200
Day's Range9.22 - 9.33
52 Week Range4.30 - 13.66
Volume798,117
Avg. Volume1,809,989
Market Cap466.47M
Beta (5Y Monthly)1.31
PE Ratio (TTM)N/A
EPS (TTM)-1.91
Earnings DateNov 02, 2021 - Nov 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for FLXN

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Flexion Therapeutics, Inc.
    Analyst Report: Eli Lilly and CompanyEli Lilly is a drug firm with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
    Rating
    Fair Value
    Economic Moat
    yesterdayMorningstar
View more
Advertisement
Advertisement